Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Titel:
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Auteur:
Dimopoulos, Meletios A Trotman, Judith Tedeschi, Alessandra Matous, Jeffrey V Macdonald, David Tam, Constantine Tournilhac, Olivier Ma, Shuo Oriol, Albert Heffner, Leonard T Shustik, Chaim García-Sanz, Ramón Cornell, Robert F de Larrea, Carlos Fernández Castillo, Jorge J Granell, Miquel Kyrtsonis, Marie-Christine Leblond, Veronique Symeonidis, Argiris Kastritis, Efstathios Singh, Priyanka Li, Jianling Graef, Thorsten Bilotti, Elizabeth Treon, Steven Buske, Christian